Now available: Intranasal BRD vaccine against both viral and bacterial pneumonia
August 14, 2025
Veterinarians and dairy producers can now purchase Bovilis® Nasalgen® 3-PMH, the first and only intranasal BRD vaccine that provides protection against both viral and bacterial pneumonia. This vaccine protects against five major causes of respiratory disease in one dose – IBR, BRSV, PI3 and Pasteurella multocida and Mannheimia haemolytica.
Approved for use in dairy and beef cattle, this intranasal vaccine provides early, broad-spectrum respiratory protection in a needle-free, animal-friendly administration. Results of efficacy, duration of immunity and safety studies demonstrate the vaccine is safe and effective for calves 1 week of age or older, pregnant cows and calves nursing pregnant cows.
The vaccine is administered in a single 2-mL dose. It contains a unique BluShadowTM diluent that clearly indicates which animals have been vaccinated. It is available in single dose/2-mL, 10-dose/20-mL and 50-dose/100-mL packages.
To learn more about the newest option in intranasal respiratory vaccines, visit Nasalgen.com, or contact your Merck Animal Health representative.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global